Advertisement
Screener

Nautilus Biotechnology, Inc. (NAUT) Scorecard

Nautilus Biotechnology, Inc. (NAUT) Scorecard

  • 2026-Q2: Total return Lose; Revenue growth No data; EPS growth No data.
  • 2026-Q1: Total return Win; Revenue growth No data; EPS growth Lose.
  • 2025-Q4: Total return Win; Revenue growth No data; EPS growth Lose.
  • 2025-Q3: Total return Win; Revenue growth No data; EPS growth Lose.
14/40 1.8 / 5 stars All 40 Win/Lose results and 80 gray no-data contests shown below

Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.

Trailing 1 year (4 quarters): 3 wins, 4 losses, 5 no dataLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q20/1 LoseNAUT / S&P
-51.80% / 15.20%
No dataNAUT / S&P
/ 15.00%
No dataNAUT / S&P
/ 50.40%
2026-Q11/2 WinNAUT / S&P
98.97% / -4.33%
No dataNAUT / S&P
/ 11.30%
LoseNAUT / S&P
-14.81% / 27.70%
2025-Q41/2 WinNAUT / S&P
130.77% / 2.65%
No dataNAUT / S&P
/ 9.00%
LoseNAUT / S&P
-16.07% / 13.40%
2025-Q31/2 WinNAUT / S&P
16.55% / 8.12%
No dataNAUT / S&P
/ 4.61%
LoseNAUT / S&P
-10.71% / 13.45%
2025-Q20/2 LoseNAUT / S&P
-15.80% / 10.94%
No dataNAUT / S&P
/ 4.83%
LoseNAUT / S&P
-7.14% / 10.63%
2025-Q10/2 LoseNAUT / S&P
-48.75% / -4.27%
No dataNAUT / S&P
/ 4.98%
LoseNAUT / S&P
-1.82% / 10.57%
2024-Q41/2 LoseNAUT / S&P
-41.05% / 2.41%
No dataNAUT / S&P
/ 5.25%
WinNAUT / S&P
7.69% / 6.15%
2024-Q32/2 WinNAUT / S&P
21.79% / 5.89%
No dataNAUT / S&P
/ 5.89%
WinNAUT / S&P
16.67% / 6.11%
2024-Q21/2 LoseNAUT / S&P
-20.41% / 4.28%
No dataNAUT / S&P
/ 5.38%
WinNAUT / S&P
21.74% / 5.12%
2024-Q11/2 LoseNAUT / S&P
-1.67% / 10.56%
No dataNAUT / S&P
/ 5.71%
WinNAUT / S&P
22.22% / 5.59%
2023-Q41/2 LoseNAUT / S&P
-5.38% / 11.69%
No dataNAUT / S&P
/ 6.81%
WinNAUT / S&P
13.04% / 7.78%
2023-Q31/2 LoseNAUT / S&P
-18.35% / -3.27%
No dataNAUT / S&P
/ 7.52%
WinNAUT / S&P
-2.04% / -5.03%
2023-Q22/2 WinNAUT / S&P
39.71% / 8.74%
No dataNAUT / S&P
/ 9.50%
WinNAUT / S&P
-8.00% / -8.57%
2023-Q11/2 WinNAUT / S&P
53.89% / 7.50%
No dataNAUT / S&P
/ 10.77%
LoseNAUT / S&P
-21.05% / -15.69%
2022-Q40/2 LoseNAUT / S&P
-15.09% / 7.56%
No dataNAUT / S&P
/ 11.88%
LoseNAUT / S&P
-33.33% / -17.99%
2022-Q30/2 LoseNAUT / S&P
-21.19% / -4.88%
No dataNAUT / S&P
/ 13.47%
LoseNAUT / S&P
-33.78% / -1.41%
2022-Q20/2 LoseNAUT / S&P
-38.02% / -16.10%
No dataNAUT / S&P
/ 13.71%
LoseNAUT / S&P
-33.33% / 11.04%
2022-Q10/2 LoseNAUT / S&P
-16.22% / -4.60%
No dataNAUT / S&P
/ 15.97%
LoseNAUT / S&P
-16.18% / 42.23%
2021-Q40/1 LoseNAUT / S&P
-15.64% / 11.03%
No dataNAUT / S&P
/ 15.00%
No dataNAUT / S&P
/ 96.40%
2021-Q30/1 LoseNAUT / S&P
-39.21% / 0.58%
No dataNAUT / S&P
/ 10.77%
No dataNAUT / S&P
/ 69.42%
2021-Q20/1 LoseNAUT / S&P
-26.71% / 8.55%
No dataNAUT / S&P
/ 6.58%
No dataNAUT / S&P
/ 51.81%
2021-Q11/1 WinNAUT / S&P
27.00% / 6.17%
No dataNAUT / S&P
/ -1.06%
No dataNAUT / S&P
/ 7.39%
2020-Q40/1 LoseNAUT / S&P
0.32% / 12.15%
No dataNAUT / S&P
/ -3.72%
No dataNAUT / S&P
/ -33.42%
2020-Q30/0 No dataNAUT / S&P
/ 8.93%
No dataNAUT / S&P
/ -2.04%
No dataNAUT / S&P
/ -27.10%
2020-Q20/0 No dataNAUT / S&P
/ 20.54%
No dataNAUT / S&P
/ -0.46%
No dataNAUT / S&P
/ -27.11%
2020-Q10/0 No dataNAUT / S&P
/ -19.60%
No dataNAUT / S&P
/ 3.47%
No dataNAUT / S&P
/ -14.75%
2019-Q40/0 No dataNAUT / S&P
/ 9.07%
No dataNAUT / S&P
/ 5.36%
No dataNAUT / S&P
/ 2.99%
2019-Q30/0 No dataNAUT / S&P
/ 1.70%
No dataNAUT / S&P
/ 5.02%
No dataNAUT / S&P
/ 0.21%
2019-Q20/0 No dataNAUT / S&P
/ 4.30%
No dataNAUT / S&P
/ 6.64%
No dataNAUT / S&P
/ 8.65%
2019-Q10/0 No dataNAUT / S&P
/ 13.65%
No dataNAUT / S&P
/ 8.12%
No dataNAUT / S&P
/ 14.29%
2018-Q40/0 No dataNAUT / S&P
/ -13.52%
No dataNAUT / S&P
/ 9.05%
No dataNAUT / S&P
/ 18.23%
2018-Q30/0 No dataNAUT / S&P
/ 7.71%
No dataNAUT / S&P
/ 10.21%
No dataNAUT / S&P
/ 19.06%
2018-Q20/0 No dataNAUT / S&P
/ 3.43%
No dataNAUT / S&P
/ 9.03%
No dataNAUT / S&P
/ 14.46%
2018-Q10/0 No dataNAUT / S&P
/ -0.76%
No dataNAUT / S&P
/ 7.68%
No dataNAUT / S&P
/ 12.46%
2017-Q40/0 No dataNAUT / S&P
/ 6.64%
No dataNAUT / S&P
/ 7.03%
No dataNAUT / S&P
/ 13.82%
2017-Q30/0 No dataNAUT / S&P
/ 4.48%
No dataNAUT / S&P
/ 5.68%
No dataNAUT / S&P
/ 17.57%
2017-Q20/0 No dataNAUT / S&P
/ 3.09%
No dataNAUT / S&P
/ 4.83%
No dataNAUT / S&P
/ 17.74%
2017-Q10/0 No dataNAUT / S&P
/ 6.07%
No dataNAUT / S&P
/ 3.67%
No dataNAUT / S&P
/ 13.32%
2016-Q40/0 No dataNAUT / S&P
/ 3.82%
No dataNAUT / S&P
/ 2.09%
No dataNAUT / S&P
/ 7.05%
2016-Q30/0 No dataNAUT / S&P
/ 3.85%
No dataNAUT / S&P
/ 0.20%
No dataNAUT / S&P
/ -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

MetricNAUT total returnS&P 500 Total Return Index
Total return32.94%20.78%
Annualized return32.94%20.78%

5Y · 2021-09-01 to 2026-08-27

MetricNAUT total returnS&P 500 Total Return Index
Total return-88.23%83.14%
Annualized return-34.81%12.86%

10Y · 2020-08-07 to 2026-08-27

MetricNAUT total returnS&P 500 Total Return Index
Total return-91.34%319.30%
Annualized return-21.70%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quanterix Corp (QTRX)United States$0.150B-1.65
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15